Phase III trial of gemcitabine plus docetaxel versus capecitabine plus docetaxel with planned crossover to the alternate single agent in metastatic breast cancer.

Saved in:
Bibliographic Details
Title: Phase III trial of gemcitabine plus docetaxel versus capecitabine plus docetaxel with planned crossover to the alternate single agent in metastatic breast cancer.
Authors: Seidman AD; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York. Electronic address: seidmana@mskcc.org., Brufsky A; Women's Cancer Center, Magee Women's Hospital, Pittsburgh., Ansari RH; Michiana Hematology Oncology, South Bend., Hart LL; Florida Cancer Specialists, Venice., Stein RS; Department of Molecular Physiology and Biophysics, Vanderbilt-Ingram Cancer Center, Nashville., Schwartzberg LS; Hematology and Medical Oncology, The West Clinic, Memphis, USA., Stewart JF; Calvary Mater Hospital, Waratah, Australia., Russell CA; Department of Clinical Medicine, University of Southern California, Los Angeles, USA., Chen SC; Department of Surgery, Chang Gung Memorial Hospital, Taipei, Taiwan., Fein LE; Centro de Oncologia Rosario, Santa Fe, Argentina., De La Cruz Vargas JA; Department of Oncology and Clinical Research, Acapulco Oncology Group, Acapulco, Mexico., Kim SB; Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea., Cavalheiro J; Hospital de Clinicas, Porto Alegre, Brazil., Zhao L; Lilly USA, LLC, Indianapolis., Gill JF; Lilly USA, LLC, Indianapolis., Obasaju CK; Lilly USA, LLC, Indianapolis., Orlando M; Eli Lilly and Company, Indianapolis, USA., Tai DF; Lilly USA, LLC, Indianapolis.
Source: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2011 May; Vol. 22 (5), pp. 1094-1101. Date of Electronic Publication: 2010 Nov 17.
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1569-8041
DOI:10.1093/annonc/mdq578